Recent Advances in Fucoidan Bioactivity and Its Molecular Mechanisms in the Intervention of Vascular Cognitive Impairment
Marine Drugs · 2026
DOI: 10.3390/md24100341 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Marine Drugs, 2026. Verfasst von Jianing Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Shandong Key Laboratory of Neurorehabilitation, Qingdao Hospital, University of Health and Rehabilitation Sciences (Qingdao Municipal Hospital), Qing…. Hauptthemen laut MEDLINE: Polysaccharides, Neuroprotective Agents, Cognitive Dysfunction. Die Arbeit nennt 142 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, the Natural Science Foundation of Shandong Province, Shandong Province Medical and Health Science and Technology Project.
Abstract (Originalsprache)
Fucoidan is a class of sulfated polysaccharides primarily derived from marine organisms, particularly brown algae and some marine invertebrates. Owing to its structural diversity and broad spectrum of biological activities, including immunomodulatory, anti-inflammatory, antioxidant, vascular protection, anticoagulant, and neuroprotective effects, fucoidan has attracted increasing attention as a promising candidate for functional foods and pharmaceutical applications. This review systematically summarizes the sources and distribution of fucoidan, modern extraction and preparation strategies, chemical structural characteristics, and structure–activity relationships. The biological activities and potential mechanisms of action of fucoidan were the primary focus of this study. Furthermore, this review provides an overview of the molecular mechanisms underlying the protective effects of fucoidan against vascular cognitive impairment. These mechanisms mainly involve the inhibition of NF-κB- and MAPK-mediated neuroinflammatory responses, activation of the Nrf2/HO-1 antioxidant pathway to alleviate oxidative stress, regulation of microglial polarization, maintenance of blood–brain barrier integrity, promotion of neurotrophic factor expression, modulation of autophagy and apoptosis-related pathways, and attenuation of microvascular damage induced by chronic cerebral hypoperfusion through VEGF signaling. Given its multi-target and multi-pathway regulatory properties, fucoidan exhibits promising potential for the prevention and management of vascular cognitive impairment and related neurodegenerative disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shandong Key Laboratory of Neurorehabilitation, Qingdao Hospital, University of Health and Rehabilitation Sciences (Qingdao Municipal Hospital), Qingdao 266071, China.
- School of Pharmacy, Qingdao University Medical College, Qingdao 266073, China.
- NHC Key Laboratory of Cardiopulmonary Rehabilitation and Functional Recovery, University of Health and Rehabilitation Sciences, Qingdao 266071, China.
Förderung
- National Natural Science Foundation of China
- the Natural Science Foundation of Shandong Province
- Shandong Province Medical and Health Science and Technology Project
- A Project of Shandong Province Higher Educational Science and Technology Program
- the Qingdao Key Medical and Health Discipline Project
- Natural Science Foundation of Shandong Province
- Qingdao Key Medical and Health Discipline Project
Zitieren
APA
Wang, J., Qu, Y., Sun, M., Zhao, Y., Bai, Y., Shi, J., Li, Y., Gao, C., Yu, M., & Han, W. (2026). Recent Advances in Fucoidan Bioactivity and Its Molecular Mechanisms in the Intervention of Vascular Cognitive Impairment. Marine Drugs. https://doi.org/10.3390/md24100341
Vancouver
Wang J, Qu Y, Sun M, Zhao Y, Bai Y, Shi J, et al. Recent Advances in Fucoidan Bioactivity and Its Molecular Mechanisms in the Intervention of Vascular Cognitive Impairment. Marine Drugs. 2026. doi:10.3390/md24100341
BibTeX
@article{Wang2026,
author = {Wang, Jianing and Qu, Yingrui and Sun, Meng and Zhao, Yumeng and Bai, Yihang and Shi, Jingxuan and Li, Yibo and Gao, Chao and Yu, Ming and Han, Wenwei},
title = {Recent Advances in Fucoidan Bioactivity and Its Molecular Mechanisms in the Intervention of Vascular Cognitive Impairment},
journal = {Marine Drugs},
year = {2026},
doi = {10.3390/md24100341}
}
EUVIMED